TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ABVX

Abivax S.A.

Healthcare · Biotechnology

105.00$ -1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Abivax S.A. (ABVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 584 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABVX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
38 76 61 54 54 52 71 109 76 327 205 584
5.6 43 28 21 21 18 38 75 36 286 171 551
1.2 25 7.9 1.9 8.0 9.8 29 61 27 252 144 516
2.9 39 23 17 13 9.8 29 61 27 261 144 530
2.4 3.9 4.8 3.6 7.8 7.0 8.0 8.3 8.3 19 16 10
0.1 0.1 0.2 1.2 1.1 4.0 12 -5.9
0.1 0.1 0.3 1.6
32 32 32 32 32 32 32 33 18 18 18 18
0.0 0.0 0.1 0.1 -0.6 6.6 6.6 6.6 6.6
4.0 4.5 3.9 5.6 19 33 53 83 68 131 165 129
1.9 3.7 3.5 5.4 8.5 12 19 32 51 88 93 63
0.0 0.3 0.3 0.2 11 21 0.0 10 30 31 44 29
1.1 2.8 2.6 4.2 6.7 11 17 19 15 47 44 38
21 28 53 37 45 52
34 72 57 48 35 19 18 26 7.2 196 41 455
-5.1 -21 -35 -47 -62 -93 -38 -82 -144 -283 -439 -738
9.3 9.7 9.7 9.9 10 12 14 15 19 43 63 70

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?